Coeliac Disease Clinical Trials
3 recruiting trials for Coeliac Disease. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Coeliac Disease clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Sheffield Teaching Hospitals NHS Foundation Trust (2), University of Pecs (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Virtual Dietetic First-Appointment Webinar for Coeliac Disease (other, 1 trial), followed by Standard Dietetic Consultation (Face-to-Face or Telephone), Symprove Probiotic.
Track Coeliac Disease trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Virtual Dietetic Interventions in Patients With Coeliac
This clinical study is exploring whether a pre-recorded, on-demand webinar led by specialist dietitians can be as effective as traditional one-on-one appointments in helping...
Efficacy of Symprove Probiotics in Coeliac Disease
Coeliac Disease (CD) is a lifelong autoimmune condition where eating gluten (a protein found in wheat, barley, and rye) causes damage to the small intestine. It affects around 1...
Cardiovascular Risk Factors in Coeliac Disease: a Series of Studies
This investigation examines the most important cardiovascular risk factors (e.g., metabolic parameters, body composition) and their changes in coeliac disease. The series of...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Coeliac Disease, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Coeliac Disease, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Coeliac Disease, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.